BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2010
View Archived Issues
TCF4 gene variation implicated in Fuchs' corneal dystrophy
Read More
First selective Aurora kinase A inhibitors identified
Read More
Fixed-dose fenofibrate/pravastatin plus ezetimibe reduces hyperlipidemia in type 2 diabetes
Read More
High loading dose of clopidogrel may overcome effects of CYP2C19 genetic variant in persons with CAD
Read More
Multiple dosing of AMG-853 well tolerated in healthy volunteers
Read More
Kowa discloses new angiotensin antagonists/PPARgamma ligands
Read More
New inhibitors of IgE Fc receptor described by Fujitsu
Read More
Favorable safety and pharmacokinetics seen in phase I trials of anti-CMV agent AIC-246
Read More
New vancomycin carbamate derivative shows potent antibacterial activity in drug-resistant strains
Read More
FDA grants orphan drug status for DasKloster-0210
Read More
Micromet begins phase II trial of its BiTE antibody blinatumomab in ALL
Read More
FDA provides guidance to Apricus on phase III study RayVa trial
Read More
Global Health Ventures begins developing sublingual telcagepant for migraine
Read More
Topica announces sublicensing agreement for luliconazole for tinea infections
Read More
PTC receives FDA grant for phase III cystic fibrosis trial
Read More
Celldex begins phase IIb trial of CDX-011 in breast cancer
Read More
Relypsa completes financing round to support RLY-5016 development
Read More
Phase III TAMARIS trial in critical limb ischemia fails to meet primary endpoint
Read More
Cytokinetics and Amgen plan phase IIb trial of omecamtiv mecarbil in HF
Read More
Phase II trial of AERAS-402 TB vaccine candidate initiated in Kenya
Read More
FDA grants Novartis approval for Gilenya for the treatment of relapsing MS
Read More
Santhera to file MAA for use of Catena in Leber's hereditary optic neuropathy
Read More
Vermillion receives CE mark for OVA1 test for ovarian cancer detection
Read More